Wendy Kays
Adult Health · Miami, FLNPI 1760932404
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.3% of the total across 458 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 13 manufacturers reported payments, led by Viiv Healthcare Company at 48.9% of the total. Among adult health clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 458 payments — averaging $28.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Viiv Healthcare Company$6K
- Gilead$3K
- Theratechnologies Inc.$1K
- Johnson & Johnson$835
- Merck$469
- Lilly USA, LLC$301
- plus $566 from 7 others
Across 8 payments — averaging $103.19 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Viiv Healthcare Company$826
What the payments were for
- Travel & lodging$190%
- Food & beverage$12,80399%
- Education$711%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Viiv Healthcare Company | 217 | $6,304 |
| Gilead | 121 | $3,316 |
| Theratechnologies Inc. | 27 | $1,101 |
| Johnson & Johnson(2 entities) | 47 | $835 |
| Merck | 22 | $469 |
| Lilly USA, LLC | 6 | $301 |
| Janssen Products, LP | 2 | $178 |
| EMD Serono, Inc. | 4 | $160 |
| Exact Sciences | 5 | $96 |
| Napo Pharmaceuticals Inc | 3 | $63 |
| AbbVie | 2 | $32 |
| Novo Nordisk | 1 | $23 |
| GSK | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$12,893 in reported general payments places this provider in the 95th percentile of 2,237 adult health providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BiktarvyBictegrav/Emtricit/Tenofov Ala | 177 | $723,000 |
| DovatoDolutegravir Sodium/Lamivudine | 67 | $199,692 |
| SymtuzaDarunavir/Cob/Emtri/Tenof Alaf | 27 | $163,447 |
| GenvoyaElviteg/Cob/Emtri/Tenof Alafen | 12 | $44,277 |
| JanuviaSitagliptin Phosphate | 23 | $24,529 |
| Megestrol Acetate | 13 | $2,097 |
| ValacyclovirValacyclovir Hcl | 19 | $1,025 |
| Rosuvastatin Calcium | 51 | $876 |
| Ventolin HfaAlbuterol Sulfate | 11 | $642 |
| Diclofenac Sodium | 14 | $261 |
| Atorvastatin Calcium | 28 | $248 |
| Acyclovir | 15 | $248 |
| Ibuprofen | 24 | $243 |
| Omeprazole | 15 | $217 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 11 | $216 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GileadBiktarvy, Genvoya | $3,316 | $767,278189 claims |
| Viiv Healthcare CompanyDovato | $6,304 | $199,69267 claims |
| Janssen Products, LPSymtuza | $178 | $163,44727 claims |
| MerckJanuvia | $469 | $24,52923 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,237 adult health providers in Florida.
Other adult health in Miami
- Norma SolisMiami$150K
- Jeffrey HernandezMiami$122K
- Kristen NievesMiami$16K
- Jose ChamorroMiami$15K
- Patricia PagnottaMaitland$409K
- Carly KoelschSarasota$265K
- Ashley PontenbergWinter Park$136K
- Jamie JohnsonTampa$58K
- Jessica MangesClearwater$52K
- Sita SwamyOrlando$49K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.